Understanding BPC-157: A closer look at the healing peptide

BPC-157, short for Body Protection Compound 157, is a synthetic peptide isolated from a naturally-occurring protein found in human gastric juice. Over the past three decades, it has become one of the most extensively studied peptides in preclinical models of tissue healing.

Proposed mechanisms

Current research suggests BPC-157 operates through several intersecting pathways. The most well-characterised is the upregulation of vascular endothelial growth factor receptor-2 (VEGFR-2), which drives new blood vessel formation and improves perfusion of damaged tissue. In parallel, the peptide appears to modulate the nitric oxide (NO) system, which plays a role in vascular tone, wound repair, and inflammatory response.

BPC-157 has also been shown to influence growth-factor signalling — most notably TGF-β and FGF pathways — that coordinate collagen deposition and fibroblast activity during tissue repair.

Stability and reconstitution

One of BPC-157's practical advantages in a laboratory setting is unusual stability: unlike many peptides, it resists hydrolysis in gastric acid, which is why some researchers use oral administration in animal studies. In its lyophilized form, properly stored at -20°C, it remains stable for months.

Research use only

As with every compound sold on Purity Peptides, BPC-157 is intended strictly for in-vitro and preclinical research applications. It is not a medicine, has not been evaluated by the FDA, and is not for human consumption.